eGenesis Company
Xenotransplant
Investors
Founded Date:
2014
Last Funding Type:
Series C
Headquarters:
USA
Investors Number:
27
Employee Number:
11-50
Industry:
Risk Mitigation
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Investor Type:
Late Stage Venture
Total Funding:
$265.00